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Objective: To present prenatal diagnosis and molecular cytogenetic characterization of a de novo 5q35
microdeletion associated with Sotos syndrome.
Methods: This was the ﬁrst pregnancy of a 29-year-old woman. The pregnancy was uneventful until 27
weeks of gestation when left ventriculomegaly was ﬁrst noted. At 31 weeks of gestation, poly-
hydramnios, macrocephaly, and ventriculomegaly were prominent on ultrasound, and left pyelectasis
and bilateral ventriculomegaly were diagnosed on magnetic resonance imaging. The woman underwent
amniocentesis and cordocentesis at 32 weeks of gestation. Conventional cytogenetic analysis was per-
formed using cultured amniocytes and cord blood lymphocytes. Array comparative genomic hybridi-
zation (aCGH) was performed on uncultured amniocytes and parental blood. Metaphase ﬂuorescence in
situ hybridization (FISH) was performed on cultured lymphocytes.
Results: Conventional cytogenetics revealed a karyotype of 46,XX. aCGH on uncultured amniocytes
revealed a de novo 1.07-Mb microdeletion at 5q35.2eq35.3 encompassing NSD1. Metaphase FISH analysis
on the cord blood lymphocytes conﬁrmed the deletion at 5q35.2. The postnatal phenotype was
consistent with Sotos syndrome.
Conclusion: Fetuses with Sotos syndromemay present macrocephaly, polyhydramnios, ventriculomegaly,
and pyelectasis in the third trimester. aCGH and metaphase FISH are useful for rapid diagnosis of 5q35
microdeletion associated with Sotos syndrome.
Copyright © 2014, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All
rights reserved.s and Gynecology, Mackay
Road, Taipei, Taiwan.
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Sotos syndrome (OMIM 117550) is an autosomal dominant
disorder that is characterized by cardinal features of macrocephaly
with a high broad forehead, an inverted pear-like head, sparseby Elsevier Taiwan LLC. All rights reserved.
Fig. 1. Prenatal ultrasound at 35 weeks of gestation shows (A) ventriculomegaly and (B) left pyelectasis.
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sures, a long face, a pointed chin, learning disability, and over-
growth; major features of advanced bone age, abnormal X-ray
ﬁndings of the skull, poor feeding, hypotonia, neonatal jaundice,
seizures, scoliosis, cardiac and renal abnormalities, joint laxity, and
pes planus; and minor features of neoplasm development such as
sacrococcygeal teratoma, presacral ganglioma, neuroblastoma,
acute lymphoblastic leukemia, small cell lung cancer, Wilms tumor,
hepatocellular carcinoma, cardiac/ovarian ﬁbroma, and germ cell
tumor [1e5]. The incidence of Sotos syndrome is estimated to be
1:14,000 live births [5].
Prenatal diagnosis of Sotos syndrome associated with a de novo
5q35 microdeletion is very rare. Here, we present molecular cyto-
genetic characterization in such a case.
Materials and methods
Clinical description
This was the ﬁrst pregnancy of a 29-year-old woman. Her hus-
band was aged 28 years, and there was no family history of
congenital malformations. The pregnancy was uneventful until 27
weeks of gestation when left ventriculomegaly (ventricular
diameter ¼ 1.3 cm) was ﬁrst noted. At 31 weeks of gestation, pol-
yhydramnios, macrocephaly (biparietal diameter ¼ 8.87 cm; 33
weeks) and ventriculomegaly were prominent (Fig. 1). Magnetic
resonance imaging at 31 weeks of gestation showed left pyelectasis
and mild dilation of the ventricular diameter in bilateral temporalFig. 2. Magnetic resonance imaging analysis at 31 weeks of gestation shows (A) mild dila
kidney.horns of lateral ventricles (left side ¼ 1.5 cm; right side ¼ 1.3 cm;
Fig. 2). The woman underwent amniocentesis and cordocentesis at
32 weeks of gestation. Conventional cytogenetic analysis was per-
formed using cultured amniocytes and cord blood lymphocytes.
Array comparative genomic hybridization (aCGH) was performed
using uncultured amniocytes. No cytogenetic abnormality was
found by conventional cytogenetics. However, aCGH and meta-
phase ﬂuorescence in situ hybridization (FISH) detected a 5q35
microdeletion. Sotos syndrome caused by chromosomal micro-
deletion was diagnosed. At 36 weeks of gestation, a 2800-g female
baby was delivered with macrocephaly and characteristic cranio-
facial appearance of Sotos syndrome.
Conventional cytogenetic analysis
Routine cytogenetic analysis by G-banding techniques at the
550 bands of resolution was performed. Amniotic ﬂuid and um-
bilical cord blood were collected, and the samples were subjected
to cell culture according to the standard cytogenetic protocol.
aCGH
Whole-genome aCGH on the DNAs extracted from uncultured
amniocytes derived from 10mL of amniotic ﬂuid and parental blood
was performed using the NimbleGen ISCA Plus Cytogenetic Array
(Roche NimbleGen, Madison, WI, USA), which has 630,000 probes
and a median resolution of 15e20 kb across the entire genome ac-
cording to themanufacturer's instruction. The DNA from unculturedtion of bilateral lateral ventricles (arrows) and (B) left pyelectasis and a normal right
Fig. 4. Metaphase ﬂuorescence in situ hybridization on the cultured cord blood lym-
phocytes using a 5p15.33-speciﬁc probe RP11-325I22 (FITC, green spectrum) and a
5q35.2-speciﬁc probe RP11-627M5 (Texas red, red spectrum) shows both red and
green signals in the normal chromosome 5 (chr5) and only the green signal in the
aberrant chromosome 5 of del(5)(q35.2q35.3).
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manufacturer's protocol of QIAamp DNA Mini kit (Qiagen, Inc.,
Valencia, CA, USA). Then, the 0.5 mg of the extracted DNAwas labeled
in Cy5 dye compared with equivalent amount of normal female
genomicDNA(G1521, Promega,Madison,WI,USA) labeled inCy3dye
to perform the aCGH experiment. The experiment was performed
according to the procedures recommended in the user guide for
Roche NimbleGen ISCA plus Cytogenetic Array. The datawere ﬁnally
represented using Nexus 6.1 (BioDiscovery, Hawthorne, CA, USA).
FISH
Metaphase FISH analysis was performed on cultured cord blood
lymphocytes using a 5p15.33-speciﬁc bacterial artiﬁcial chromo-
some probe RP11-325I22 (1,318,107e1,509,826) [hg 19] (FITC, green
spectrum) and a 5q35.2-speciﬁc bacterial artiﬁcial chromosome
probe RP11-627M5 (176,360,255e176,543,816; Texas red, red
spectrum) according to the standard FISH protocol.
Results
G-banded chromosome analysis of cord blood and amniocytes
revealed a karyotype of 46,XX. aCGH on the DNA extracted from the
uncultured amniocytes detected a de novo 1.07-Mb microdeletion
at 5q35.2eq35.3 or arr 5q35.2q35.3 (175,821,192e176,892,141)  1
(Fig. 3). The deleted region contains 31 genes including 19 OMIM
genes: CLTB, GPRIN1, SNCB, UNC5A, HK3, UIMC1, ZNF346, FGFR4,
NSD1, RAB24, PRELID1, MXD3, LMAN2, RGS14, SLC34A1, PFN3, F12,
GRK6, and DBN1. The deletion of NSD1 is associated with Sotos
syndrome. aCGH analysis of the parents' blood did not reveal such a
microdeletion. Metaphase FISH analysis of the cord blood
conﬁrmed the deletion at 5q35.2 (Fig. 4).
Discussion
The present case had a 1.07-Mb microdeletion at 5q35.2eq35.3
encompassing the NSD1 gene. Sotos syndrome is caused by aFig. 3. Array comparative genomic hybridization on the DNA extracted from the uncultu
(175,821,192e176,892,141)  1. The deleted region contains the NSD1 gene.deletion or mutation in the NSD1 gene (OMIM 606681). The NSD1
gene maps to 5q35.2eq35.3 (176,560,025e176,727,213) [6e8].
Stratton et al [9] reported a patient with deletion of 5q35.3 and the
phenotype of macrocephaly and developmental delay. Maroun et al
[10] in 1994 ﬁrst described a female patient with Sotos syndrome
and a karyotype of 46,XX,t(5;15) (q35;q22), and suggested that
5q35 as the gene locus associated with Sotos syndrome. Imaizumi
et al [11] in 2002 reported a female patientwith Sotos syndromeand
a karyotype of 46,XX,t(5;8) (q35;q24.1), and suggested that the gene
responsible for Sotos syndrome is located at 5q35. Kurotaki et al [7]
subsequently in 2002, by positional cloning of the 5q35 breakpoint,red amniocytes shows a 1.07-kb microdeletion at 5q35.2eq35.3 or arr 5q35.2q35.3
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et al [12] reported a 6-year-old boy with tall stature, macrocephaly,
typical facial appearance, learning disability, megaloencephaly,
corpus callosum dysgenesis, and colpocephaly associated with a
5q35 microdeletion spanning the NSD1 locus at 5q35.3.
The NSD1 gene encodes nuclear receptor set domain protein 1,
which enhances androgen receptor transactivation [13]. About 90%
of patients with Sotos syndrome have NSD1 abnormalities
including intragenic mutations and microdeletion. However, in
about 10% of classic Sotos syndrome cases, NSD1 abnormalities
cannot be identiﬁed [14,15]. The 5q35 microdeletion causes about
50% of Japanese Sotos syndrome cases, and about 10e15% of non-
Japanese Sotos syndrome cases, while intragenic mutations of
NSD1 cause about 12% of Japanese Sotos syndrome cases and
27e93% of non-Japanese Sotos syndrome cases [5,14e25]. In a
study of 18 unrelated Korean patients with Sotos syndrome, Sohn
et al [26] found that eight patients (53%) had 5q35 microdeletions,
and 47% had different NSD1 intragenic mutations. Familial Sotos
syndrome occurs in < 10% of the cases with Sotos syndrome, and
most cases with Sotos syndrome are sporadic [15,22,27].
The present case was associated with prenatal ultrasound
ﬁndings of fetal overgrowth, macrocephaly, ventriculomegaly,
polyhydramnios, and pyelectasis in the third trimester. Prenatal
sonographic observations of fetal overgrowth, macrocephaly, pol-
yhydramnios, and renal and central nervous system abnormalities
in association with increased nuchal translucency and abnormal
maternal serum screen result should include a differential diag-
nosis of Sotos syndrome [4,28e30]. Chen et al [28] reported pre-
natal third-trimester ultrasound ﬁndings of fetal macrocephaly,
ventriculomegaly, corpus callosum hypoplasia, enlarged cistern
magna, unilateral hydronephrosis, polyhydramnios, and over-
growth in a pregnancy with familial Sotos syndrome and an
abnormal maternal serum screen result for Down syndrome in the
second trimester. Thomas and Lemire [29] reported prenatal third-
trimester ultrasound ﬁndings of macrocephaly and poly-
hydramnios in a pregnancy with familial Sotos syndrome and an
abnormal maternal serum screen result for Down syndrome in the
second trimester. Schou et al [30] reported increased nuchal
translucency and large for date in a fetus with a de novo Sotos
syndrome. The central nervous system abnormalities associated
with Sotos syndrome include enlargement of lateral ventricles,
trigones and occipital horns, corpus callosum hypoplasia, persis-
tence of cavum septum pellucidum, cavum vergae and cavum
velum interpositum, enlarged cisterna magna, heterotopias, mac-
rocerebellum, and periventricular leukomalacia [31,32].
Prenatal diagnosis of fetal overgrowth associated with Sotos
syndrome should include a differential diagnosis of other over-
growth conditions that may be confused with Sotos syndrome such
as Weaver syndrome (EZH2 microdeletions or mutations), Beck-
witheWiedemann syndrome (11p15 epigenetic and genomic
alterations), SimpsoneGolabieBehmel syndrome (GPC3, GPC4,
CXORF5microdeletions or mutations), BannayaneRileyeRuvalcaba
syndrome (PTEN microdeletions or mutations), benign familial
macrocephaly (an autosomal dominant disorder), fragile X syn-
drome [FMR1 microdeletions or mutations by trinucleotide (CGG)n
repeat expansion], Gorlin syndrome (PTCH microdeletions or mu-
tations), chromosomal abnormalities of 4p duplications, mosaic
20p trisomy and 22q13.3 deletions, and nonspeciﬁc overgrowth [5].
Prenatal diagnosis of Sotos syndrome should include parental
genetic testing since there is a 5% incidence of having an affected
parent [5]. If a parent is affected with Sotos syndrome, the recur-
rence risk is about 50%. However, if no parent is affected with Sotos
syndrome, the recurrence risk in the following pregnancy is < 1%
[2,5]. Germline mosaicism for NSD1 microdeletions or mutations
has not been reported [2].Prenatal diagnosis of fetal overgrowth, polyhydramnios, macro-
cephaly, and renal and central nervous systemabnormalities should
consider a detailed examination of the parents for the phenotypic
features of Sotos syndrome, and mutational and microdeletion
analysis of NSD1 gene in the fetus. Our case provides an example of
the usefulness of aCGH on uncultured amniocytes for rapid molec-
ular cytogenetic diagnosis of Sotos syndrome associatedwith a 5q35
microdeletion.
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